Literature DB >> 22106026

MBNL1-RNA recognition: contributions of MBNL1 sequence and RNA conformation.

Yuan Fu1, Sreenivasa Rao Ramisetty, Nejmun Hussain, Anne M Baranger.   

Abstract

Muscleblind-like proteins (MBNL) are RNA-binding proteins that bind to the poly(CUG) and poly(CCUG) sequences that are the causative agents of myotonic dystrophy. It has been suggested that as a result of binding to the repeating RNA sequences, MBNL1 is abnormally expressed and translocated, which leads to many of the misregulated events in myotonic dystrophy. In this work, steady-state fluorescence quenching experiments suggest that MBNL1 alters the structure of helical RNA targets upon binding, which may explain the selectivity of MBNL1 for less structured RNA sites. The removal of one pair of zinc fingers greatly impairs the binding affinity of MBNL1, which indicates that the two pairs of zinc fingers might possibly interact with RNA targets cooperatively. Alanine scanning mutagenesis results suggest that the binding energy may be distributed across the protein. Overall, the results presented here suggest that small molecules that stabilize the helical structure of poly(CUG) and poly(CCUG) RNAs will inhibit the formation of complexes with MBNL1.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22106026      PMCID: PMC3890438          DOI: 10.1002/cbic.201100487

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  52 in total

1.  Thermodynamic characterization of single mismatches found in naturally occurring RNA.

Authors:  Amber R Davis; Brent M Znosko
Journal:  Biochemistry       Date:  2007-10-24       Impact factor: 3.162

2.  Evidence for non-two-state kinetics in the nucleocapsid protein chaperoned opening of DNA hairpins.

Authors:  Gonzalo Cosa; Yining Zeng; Hsiao-Wei Liu; Christy F Landes; Dmitrii E Makarov; Karin Musier-Forsyth; Paul F Barbara
Journal:  J Phys Chem B       Date:  2006-02-09       Impact factor: 2.991

3.  Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.

Authors:  Mani S Mahadevan; Ramesh S Yadava; Qing Yu; Sadguna Balijepalli; Carla D Frenzel-McCardell; T David Bourne; Lawrence H Phillips
Journal:  Nat Genet       Date:  2006-07-30       Impact factor: 38.330

Review 4.  RNA-mediated neuromuscular disorders.

Authors:  Laura P W Ranum; Thomas A Cooper
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

5.  Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Jihae Shin; Yuan Yuan; Stuart G Beattie; Thurman M Wheeler; Charles A Thornton; Maurice S Swanson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 6.  The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.

Authors:  Maya Pascual; Marta Vicente; Lidon Monferrer; Ruben Artero
Journal:  Differentiation       Date:  2006-03       Impact factor: 3.880

7.  Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.

Authors:  Minqi Hao; Kevan Akrami; Ke Wei; Carlos De Diego; Nam Che; Jeong-Hee Ku; James Tidball; Michael C Graves; Perry B Shieh; Fabian Chen
Journal:  Dev Dyn       Date:  2008-02       Impact factor: 3.780

8.  Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1.

Authors:  Shin-Ichiro Hino; Shinichi Kondo; Hiroshi Sekiya; Atsushi Saito; Soshi Kanemoto; Tomohiko Murakami; Kazuyasu Chihara; Yuri Aoki; Masayuki Nakamori; Masanori P Takahashi; Kazunori Imaizumi
Journal:  Hum Mol Genet       Date:  2007-08-29       Impact factor: 6.150

9.  MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T.

Authors:  M Bryan Warf; J Andrew Berglund
Journal:  RNA       Date:  2007-10-17       Impact factor: 4.942

10.  Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs.

Authors:  Yuan Yuan; Sarah A Compton; Krzysztof Sobczak; Myrna G Stenberg; Charles A Thornton; Jack D Griffith; Maurice S Swanson
Journal:  Nucleic Acids Res       Date:  2007-08-15       Impact factor: 16.971

View more
  23 in total

1.  Pseudouridine Modification Inhibits Muscleblind-like 1 (MBNL1) Binding to CCUG Repeats and Minimally Structured RNA through Reduced RNA Flexibility.

Authors:  Elaine deLorimier; Melissa N Hinman; Jeremy Copperman; Kausiki Datta; Marina Guenza; J Andrew Berglund
Journal:  J Biol Chem       Date:  2017-01-27       Impact factor: 5.157

Review 2.  RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Authors:  Viachaslau Bernat; Matthew D Disney
Journal:  Neuron       Date:  2015-07-01       Impact factor: 17.173

3.  Combinatorial mutagenesis of MBNL1 zinc fingers elucidates distinct classes of regulatory events.

Authors:  Jamie Purcell; Julia C Oddo; Eric T Wang; J Andrew Berglund
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

4.  A novel CUG(exp)·MBNL1 inhibitor with therapeutic potential for myotonic dystrophy type 1.

Authors:  Amin Haghighat Jahromi; Lien Nguyen; Yuan Fu; Kali A Miller; Anne M Baranger; Steven C Zimmerman
Journal:  ACS Chem Biol       Date:  2013-03-20       Impact factor: 5.100

Review 5.  Circular RNA participates in the carcinogenesis and the malignant behavior of cancer.

Authors:  Zhen-Jun Zhao; Jun Shen
Journal:  RNA Biol       Date:  2015-12-09       Impact factor: 4.652

6.  Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity.

Authors:  Jessica L Childs-Disney; Ilyas Yildirim; HaJeung Park; Jeremy R Lohman; Lirui Guan; Tuan Tran; Partha Sarkar; George C Schatz; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2013-12-16       Impact factor: 5.100

Review 7.  RNA-binding protein misregulation in microsatellite expansion disorders.

Authors:  Marianne Goodwin; Maurice S Swanson
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

8.  Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model.

Authors:  Elaine deLorimier; Leslie A Coonrod; Jeremy Copperman; Alex Taber; Emily E Reister; Kush Sharma; Peter K Todd; Marina G Guenza; J Andrew Berglund
Journal:  Nucleic Acids Res       Date:  2014-10-10       Impact factor: 16.971

9.  Examining the interactions of the splicing factor MBNL1 with target RNA sequences via a label-free, multiplex method.

Authors:  Amrita R Yadav; Charles R Mace; Benjamin L Miller
Journal:  Anal Chem       Date:  2014-01-09       Impact factor: 6.986

10.  Developing bivalent ligands to target CUG triplet repeats, the causative agent of myotonic dystrophy type 1.

Authors:  Yuan Fu; Kali A Miller; Lien Nguyen; Amin Haghighat Jahromi; Long M Luu; Anne M Baranger; Steven C Zimmerman
Journal:  J Med Chem       Date:  2013-11-21       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.